Abstract
Introduction
Inflammatory bowel disease (IBD) is a chronic disorder consisting of two main pathologies:
Crohn's disease (CD) and ulcerative colitis (UC). Primarily these diseases are distinguished by severe chronic inflammation observed as transmural skip lesions throughout the intestinal tract in CD, while in UC the mucosal and submucosal inflammation continuously ascends from the rectum to colon. IBD manifestations and sequela include diarrhoea and/or constipation, ulceration, strictures, the formation of fistulae and intense abdominal pain (1) .
Due to the idiopathic nature of IBD there is no cure; thus, relief from its debilitating symptoms is paramount. Managing IBD over a long period is difficult due to either the toxicity of therapies, or refractory responses in patients (2) . The inefficacy of current treatments are highlighted by the bowel resection rate in up to 90% of CD patients (3).
Investigation of endogenous biochemical signals contributing to chronic intestinal
inflammation may lead to the development of more effective therapies.
Serotonin (5-hydroxytryptamine, 5-HT) has long been linked with intestinal diseases including CD, UC, irritable bowel syndrome (IBS), coeliac disease and diverticulitis (4) . The largest pool of 5-HT in the body is secreted by a specialised subset of enteroendocrine cells called enterochromaffin (EC) cells located throughout the intestinal tract (5) . EC cells produce 5-HT from exogenous tryptophan via tryptophan hydroxylase 1 (Tph1) and package it into vesicles for organised release. Subsequently, 5-HT acts as an agonist for a variety of 5-HT receptors; these actions conclude by the uptake of 5-HT into epithelial cells by the serotonin reuptake transporter (SERT) where it is metabolised via monoamine oxidase A (6).
5-HT release from EC cells is mechanosensitive (7) , albeit EC cells possess a variety of receptors that detect nutrients and noxious stimuli including pro-inflammatory mediators, bacterial metabolites and chemical irritants that induce 5-HT secretion (6, (8) (9) (10) . Once released, 5-HT acts in a paracrine manner stimulating both intrinsic afferent nerve terminals that regulate peristaltic reflexes (11) , and extrinsic afferent nerve terminals transmitting sensory information via vagal and spinal pathways (12) . Thus increased 5-HT release has been associated with altered motility and visceral discomfort in intestinal inflammation.
Furthermore, 5-HT alters the functions of innate leukocytes including monocytes, macrophages, dendritic cells, T and B-lymphocytes (13) . 5-HT may also have chemotactic properties on leukocytes as observed in eosinophils and dendritic cells (14, 15) .
Increased 5-HT availability has been reported in animal models of chemically-induced acute intestinal inflammation (16) (17) (18) (19) (20) . The association between 5-HT and inflammation has been further demonstrated by reduced severity of colitis in Tph1 null mice (21) . The significance of 5-HT in the inflamed gut has not been determined in a chronic model replicating the disease course of human IBD. Winnie mice with spontaneous chronic colitis are an ideal model of IBD due to its close pathophysiological resemblance to human UC (22) (23) (24) (25) (26) . These mice have a single point missense mutation in the Muc2 gene causing aberrant assembly of mucin, resulting in epithelial barrier dysfunction, and Th17 (CD4+ and interleukin 17+ Tcell)-type chronic inflammation leading to UC-like symptoms including altered gastrointestinal transit, motility and chronic diarrhoea. The objectives of this study were to define whether the levels of mucosa-derived 5-HT are changed in Winnie mice, elucidate mechanisms underlying any changes, and determine whether 5-HT levels are associated with the onset and progression of chronic colitis.
Methods

Animals
Male and female Winnie mice aged 14-16 weeks (total n=13) were obtained from the University of Tasmania (Launceston, Tasmania, Australia) and Victoria University (Melbourne, Victoria, Australia) for 5-HT measurements, immunohistochemistry and quantitative Real-Time Polymerase Chain Reaction (RT-qPCR) studies. Winnie mice were compared to aged matched male and female C57BL/6 mice (total n=10) obtained from the Animal Resource Centre (Perth, Western Australia, Australia). For disease onset and progression studies, male and female Winnie mice aged 5-6, 7-14, 15-19 and 20-25 weeks (total n=24) were obtained from the University of Tasmania (Launceston, Tasmania, Australia) and Victoria University (Melbourne, Victoria, Australia). All mice had access to food and water ad libitum, and were housed in a temperature-controlled environment with a 12-h day/night cycle. All mice were acclimatised for at least one week at the Western Centre for Health, Research and Education (Melbourne, Victoria, Australia) to reduce the environmental impact on intestinal health. Mice were killed by cervical dislocation and tissues were collected for subsequent ex vivo procedures. In humans, differential effects of 5-HT on the distal and proximal colon have been reported (27) . Furthermore, differences in colitis are observed between the distal colon and proximal colon in Winnie mice (25, 26) ; thus these tissues were separated for all subsequent experiments and analysis. All animal experiments in this study complied with the guidelines of the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes and were approved by the Victoria University Animal Experimentation Ethics Committee.
5-HT measurements
Intestinal 5-HT was measured using an electrochemical technique previously validated in multiple species including mice (16, (28) (29) (30) . Segments of the jejunum, ileum, proximal and distal colon were visualised under a dissecting microscope, cut along the mesenteric border and loosely pinned mucosal side up in a silicon-lined recording chamber. leaving ∼200μm of carbon fibre exposed at the recording tip. Within the capillary, a pellet of woods metal was used to join the remaining carbon fibre and copper wire to provide a connection point for the head-stage. Carbon fibre electrodes were voltage clamped at +400 mV; 5-HT oxidation was detected as a positive current deflection. Recordings of the current generated by the oxidation of 5-HT were made using a VA-10 amplifier (NPI Electronics, Tamm, Germany), digitized at 1-5 kHz (Digidata 1440; Axon Instruments, Union City, CA, USA) to a personal computer using PClamp 9.0 (MDS Analytical Technologies, Mississauga, ON, Canada, 0.5 kHz filtering with a 50-Hz notch filter). All manufactured electrodes were individually calibrated with a 10μL spritz of 10μM serotonin hydrochloride (Sigma-Aldrich, Sydney, Australia) in Krebs solution prior to performing recordings. A precision micromanipulator was used to compress the mucosa with the carbon fibre microelectrode to induce mechanically stimulated 5-HT release (peak) and the decay of 5-HT back to baseline levels (steady state).
Immunohistochemistry
Colonic segments were viewed under a dissection microscope, cut along the mesenteric border and pinned mucosal side up in a silicon lined Petri dish (31) . Tissues were fixed in 4%
paraformaldehyde and 3% sucrose in 0.1 M phosphate buffered saline (PBS) for 4h at 4°C.
Tissues were permeabilised in dimethyl sulfoxide (DMSO) (3x10 min) and washed with 0.1 M PBS (3x10 min) before embedding in optimal cutting temperature (OCT) compound (Tissue Tek-Sakura, Tokyo, Japan). Tissues were cut into 12μm sections using a cryostat and were mounted onto glass slides. OCT sections were allowed to thaw before incubation with 10% normal donkey serum (NDS) and 0.5% Triton X-100 diluted in 0.1 M PBS at room temperature to prevent nonspecific binding with subsequent immunolabeling. Sections were washed as described above, and incubated with rabbit anti-5-HT antiserum (1:5000;
Immunostar, Hudson, WI, USA) and 2% NDS overnight at 4°C. Sections were washed as previous, and incubated with donkey anti-rabbit IgG AlexaFluor 647 (Jackson Immunoresearch, West Grove, PA, USA) and 2% NDS for 1 h at room temperature before being counterstained with the nuclei marker, 4',6-diamidino-2-phenylindole (DAPI) for 2 min. Sections were washed prior to being mounted and coverslipped onto glass slides for imaging using DAKO mounting medium (Agilent Technologies, Melbourne, Australia).
Imaging and analysis
Immunoreactivity for 5-HT and DAPI staining was visualised using an Eclipse Ti confocal laser scanning system (Nikon, Tokyo, Japan). Z-series images were acquired using the 40X objective at a nominal thickness of 1μm (512x512 pixels). 
Disease activity index
Colitis is observed in Winnie mice by changes to colon weight and body weight, diarrhoea, rectal prolapses and rectal bleeding (25, 26) . Colitis was confirmed by a disease activity 
Statistical analysis
Data analysis was performed using GraphPad Prism v7 (GraphPad Software Inc., San Diego, CA, USA). For direct comparisons, data were analysed using Student's t-test (two-tailed). X, Y correlations were determined using a linear regression analysis with P-values for significant slope relationships recorded. For multiple groups, a one-way ANOVA was Previously it was shown that serum levels of mucosa-derived 5-HT are influenced by gender in equines (38) ; therefore the impact of gender on mucosal 5-HT release in colitis was investigated ( Figure 6C ). 5-HT concentrations obtained from male and female Winnie mice aged 15-25 weeks were compared as this age group provided the most prominent hypersecretion of 5-HT in our study. No significant differences were observed in male (n=9) and female (n=10) Winnie mice for peak (male 23.6±2.2µM, female 21.0±1.4 µM) or steady state (male: 11.5±1.3µM, female: 10.9±1.1µM) 5-HT levels.
Discussion
In this study we observed increased basal and mechanically stimulated 5-HT availability in the distal and proximal colon of Winnie mice with spontaneous chronic colitis. Correlation analysis revealed that this paralleled an increase in EC cells in the crypts of Winnie mice.
Crypt hyperplasia, as observed through an increase in crypt length and width in the distal and proximal colon of Winnie mice, strongly correlated with an increase in EC cells. However, increased 5-HT availability was not proportional to the number of EC cells alone in the distal colon of Winnie mice. Our study revealed that altered 5-HT reuptake due to the downregulation of SERT, together with EC cell hyperplasia, are the underlying mechanisms of increased 5-HT availability in Winnie mice. Furthermore, this was the first study to determine intestinal 5-HT release throughout the onset and progression of chronic colitis. We demonstrated that the hypersecretion of 5-HT parallels the disease severity during its progression which was independent of gender.
Winnie mice used in this study offer several advantages as a model of UC. Like patients with UC, these mice begin to develop spontaneous, chronic inflammation in the colon at early adulthood similar to humans (39, 40) . Furthermore, the resemblance in symptoms indicates that similar perturbations may ensue on the cellular and molecular level. Indeed the inflammatory cytokine profile and leukocyte cell populations reflect changes observed in UC patients (25, 26) . The similarities between Winnie mice and UC patients have been further confirmed by our group by determining alterations in colon morphology and neural innervation, myenteric neuronal damage, changes to colonic motility and transit time as well as faecal microbial and metabolomic profiles (22) (23) (24) 41) . Together these studies demonstrate that Winnie mice provide a robust model of UC. The beginning of disease at 7 weeks of age and chronic ongoing inflammation of the colon in Winnie mice permits long-term studies mimicking the onset and progression of UC. Previously, 5-HT levels have been measured in several models of chemically-induced colitis in guinea-pigs, rats and mice (16) (17) (18) (19) (20) . The majority of these studies investigated 5-HT concentrations in the acute models of 2,4,6-trinitrobenzenesulfonic acid (TNBS) or dextran sulphate sodium (DSS)-induced colitis 4 -7 days after the induction of inflammation. Due to the short timeframe of these studies, the association between long-term chronic inflammation and 5-HT levels was unknown. Using
Winnie mice, we were well positioned to study mucosal serotonin release throughout the disease course up to ~175 days of age. This facilitated novel findings that connected increased secretion of mucosa-derived 5-HT with the onset and progression of the disease.
In our study we observed greatly elevated 5-HT levels in the distal and proximal colon in response to chronic colitis using amperometric methods. Previous studies in murine DSS and
TNBS-induced colitis have demonstrated increased 5-HT levels in tissue homogenates
detected by ELISA (19, 20) , however no differences in 5-HT secretion where observed in TNBS-treated animals (20) . Similarly, studies in tissues from IBD patients assessing 5-HT levels by ELISA have yielded mixed results (8, 42, 43) . Using ELISA, 5-HT levels normalised to tissue weight were decreased in biopsies from UC patients and no changes in 5-HT secretion were observed in biopsy supernatants (42) . Nonetheless, 5-HT release is greatly increased EC cells isolated from CD patients compared to healthy controls when exposed to lipopolysaccharides and interleukin 1β. Furthermore, a recent comprehensive study with 75 UC patients observed increased plasma 5-HT levels which could not be explained by an association with SERT polymorphisms (44, 45) . Considering that 5-HT in the plasma is originally synthesised and released from EC cells, these results may be indicative of increased local 5-HT concentrations in the mucosa which contrasts prior findings. As previously proposed, quantifying 5-HT by ELISA can be confounded by altered mass of the inflamed tissue or mucosal damage leading to crypt loss and ulcerations, all of which are prominent in intestinal inflammation (17, 46) . Electrochemical methods of 5-HT quantification have been utilised by many labs (47, 48) and are less likely to be affected by these structural changes because normalisation to weight or reference proteins is not required. In our study, all Winnie mice with high mucosal 5-HT release had loose stool. Previously we demonstrated that diarrhoea in Winnie mice was associated with colonic dysmotility and changes in intestinal transit that are similar to IBD patients (24) . In the current study we demonstrated that both secreted 5-HT levels and disease activity progress linearly with age.
This revealed a trend in the extent of 5-HT hypersecretion with the severity of colitis, including faecal water content. Mucosa-derived 5-HT is thought to have an important role in regulating motility (52) . Thus, data presented in our study and those in IBS-d patients may indicate that hypersecretion of 5-HT is at least partially responsible for dysmotility and diarrhoea. Taken together this suggests that altered 5-HT signalling may directly influence the onset of chronic diarrhoea observed in UC. However, the parallels between 5-HT hypersecretion and colonic hypertrophy observed in our study by ratios of colon weight:length and rectal manifestations suggest that 5-HT signalling has a role in the pathophysiology of colonic inflammation and dysmotility (53) .
Due to the abundance of 5-HT receptors throughout the intestinal tract, high 5-HT levels may impact many physiological functions of the inflamed intestine; however, 5-HT may also contribute to the inflammation itself. In animal models of colitis, the importance of 5-HT in the inflammatory response has been demonstrated by applying exogenous 5-HT by enema (46, 54) or its precursor 5-hydroxytryptophan subcutaneously (21) . In these studies 5-HT exacerbated colitis in rats with TNBS-induced and mice with DSS-induced colitis establishing a strong pro-inflammatory role for 5-HT (21, 46, 54) . This is further evidenced by the abolished effects of chemical inducers of colitis in Tph1 null mice (21) and those orally administered with Tph1 inhibitors (55) . These studies demonstrate that 5-HT has a clear role in chemically-induced colitis and that this 5-HT is produced by Tph1, however mechanisms instigating this increase remain disputed. Our results demonstrated that downregulation of SERT elevates secreted 5-HT concentrations in chronic colitis as opposed to increased synthesis by Tph1. Similar observations are documented after TNBS and DSSinduced colitis in mice and guinea-pigs (16, 17, 19, 20) . Importantly, SERT expression is also reduced in colonic tissues from UC patients on the protein and transcriptional levels (42) . The reduction of SERT is observed in the inflamed mucosa; however its downregulation is also noted in the non-inflamed mucosa of UC patients (56) . Previously, it was demonstrated that media conditioned by activated T lymphocytes decreases 5-HT uptake in epithelial cells in vitro (57). T lymphocytes were found to secrete TNF-α and IFN-γ; application of these specific cytokines decreased SERT expression and 5-HT uptake with additive effects. Reactivated T lymphocytes isolated from Winnie mice show a progressive increase in TNF-α and IFN-γ secretion with disease progression and may explain how SERT was downregulated in the distal colon of Winnie mice (26). Previously, it was shown that SERT deletion exacerbates TNBS-colitis in mice, this strengthens the notion of reducing interstitial 5-HT levels to elicit an anti-inflammatory effect (58) . Moreover, it must be noted that administration of the serotonin reuptake inhibitors, fluoxetine and fluvoxamine, have been shown to ameliorate DSS and acetic acid-induced colitis, respectively (59, 60) . However, these drugs also act on many other transporters and receptors, thus their mechanisms of action are unclear.
In our study, local 5-HT measurements strongly correlated with the number of EC cells per crypt. Increased numbers of EC cells were reported in the colon of mice (16, 19) and rats (18) with DSS-induced colitis and guinea-pigs with TNBS-induced colitis (17) , however, no significant difference was observed in TNBS-exposed mice (20) . Increases in EC cell numbers are observed in UC patients (61, 62). Contrarily, EC cell numbers are decreased in severe UC but not non-severe UC, this may indicate the gross architectural damage to the colonic mucosa influences cell counts (42) . Similar elevations in EC cells numbers have been observed in CD patients (61), which is reportedly present in active CD ileitis (63) but not in non-active intestinal regions (64) . It has been demonstrated that in a murine DSS-induced colitis, EC cell hyperplasia is regulated by interleukin 13 (65) . Similar to UC, Winnie mice are dominated by the Th2 immune response, consequently, interleukin 13 production is increased in leukocytes from the mesenteric lymph nodes (25, 26) which may contribute to EC cell hyperplasia. In our study, the number of EC cells observed per crypt strongly correlated with crypt length, which is viewed as an indirect measurement of intestinal epithelial cell hyperplasia due to apical migration of superfluous cells increasing the length of the crypts (20) . Increases to the length of the crypts are regularly observed in models of chemically-induced colitis (20, 36) . In our study, chronic inflammation resulted in increased crypt length in the distal and proximal colon of Winnie mice. Increased crypt length has previously been reported in the distal colon and caecum of the Winnie mouse; however no differences were observed in the proximal colon (25) . Discrepancies in these data may be explained by the older age of Winnie mice used in the present study given that colitis exacerbates with age in Winnie mice (26) and inflammation progresses proximally in UC (66). Similar to our observations, the proportion of EC cells to epithelial cells did not change in mice with TNBS-induced colitis despite an increase in crypt length and in number of epithelial cells (20) . Together these data suggest the increased EC cell numbers were likely a result of general epithelial cell hyperplasia rather than augmented differentiation of EC cells from the epithelial stem cell pool.
All Winnie mice with colitis, regardless of gender, exhibited higher 5-HT release compared to control groups. It has previously been demonstrated that 5-HT synthesis is higher in the brain of males compared to females (67) . However, differences in 5-HT levels have also been observed in the serum of equines which indicated that potential gender differences also exist in mucosa-derived 5-HT (38) . It has long been predicted that 5-HT mediates the physiological and pathophysiological effects of oestrogen (68) . However it has only recently been demonstrated that EC cell hyperplasia is present in oestrus female mice compared to both prooestrus females and males (69). Specifically in IBS-d patients, 5-HT levels are increased in both men and women; however, in women this was dependent on the menstrual cycle with 5-HT levels normalising in women with low progesterone/oestrogen levels (70).
The menstrual cycle was not investigated in our study, however, these data may explain why 5-HT levels in female Winnie mice appeared marginally lower than in males. 
